Study data published Tuesday in JAMA suggest that women who take bisphosphonates for several years have an increased risk of atypical femur fracture. However, the researchers note that the risk of such fractures are rare and are outweighed by the benefits of the drugs for most patients.
**Published in "First Word"
Muy completo tu articulo. Visita mi blog:
ReplyDeleteSolo tu salud
Noticias de salud, informacion para el cuidado del cuerpo, consejos de belleza, dietas.